scholarly journals The Role of Cell-Free Circulating DNA in the Diagnosis and Prognosis of Breast Cancer

2021 ◽  
Vol 29 (2) ◽  
pp. 169-177
Author(s):  
Hamed Hosseinalizadeh ◽  
Mehrdad Mahmoodpour ◽  
Ammar Ebrahimi
2011 ◽  
Vol 29 (2) ◽  
pp. 124-129 ◽  
Author(s):  
Jörg Ellinger ◽  
Stefan C. Müller ◽  
Thomas C. Stadler ◽  
Andreas Jung ◽  
Alexander von Ruecker ◽  
...  

Author(s):  
Khulood M. Al-Khater ◽  
Sarah Almofty ◽  
Vijaya Ravinayagam ◽  
Noor Alrushaid ◽  
Suriya Rehman

2012 ◽  
Vol 131 (10) ◽  
pp. 2308-2319 ◽  
Author(s):  
Alexander B. Philipp ◽  
Petra Stieber ◽  
Dorothea Nagel ◽  
Jens Neumann ◽  
Fritz Spelsberg ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (33) ◽  
pp. 54537-54547 ◽  
Author(s):  
Jie Cheng ◽  
Katarina Cuk ◽  
Jörg Heil ◽  
Michael Golatta ◽  
Sarah Schott ◽  
...  

Author(s):  
F. Z. Mohammed ◽  
Lamis Gamal ◽  
Mohamed Farouk Mosa ◽  
I. M. El- Deen

Background: Breast cancer (BC) is the most common cause of malignancy in females all over the world. Continuous scientific research for the discovery of new markers helping is a cornerstone for early disease detection and proper management. Aim of the Study: This study aimed to evaluate the role of Neutrophil gelatinase-associated lipocalin (NGAL) as prognostic markers for breast cancer in an Egyptian female population. Patients and Methods: 120 BC patients and 30 healthy controls were the subjects of the study; serum NGAL levels were investigated and correlated with the clinicopathologic characteristics of the BC patients. Results: Our study showed that NGAL was significantly different between healthy controls and BC patients, and  it revealed a gradual increase with disease severity. Conclusion: Our findings suggested that NGAL could be diagnostic marker for early case detection, and was shown to be associated with breast cancer prognosis, supporting its role as prognostic biomarker.


Sign in / Sign up

Export Citation Format

Share Document